RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > In Focus: Risk Management of Medical Products

In Focus: Risk Management of Medical Products

Posted 01 July 2010

In this issue of Regulatory Focus we explore current practices for managing the risks of medical products. The US Food and Drug Administration (FDA) and its counterparts around the world are responsible for protecting public health by ensuring the safety and effectiveness of drugs and devices. To achieve this mission, regulators must decide whether a given product's benefits to patients and users outweigh its risks, while recognizing that "absolute safety" is not achievable.


© 2022 Regulatory Affairs Professionals Society.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.